


1. Q409935
| Molecular Weight | 536.5 g/mol |
|---|---|
| Molecular Formula | C20H40N3NaO10P |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 22 |
| Exact Mass | 536.23490076 g/mol |
| Monoisotopic Mass | 536.23490076 g/mol |
| Topological Polar Surface Area | 171 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 623 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Macugen |
| PubMed Health | Pegaptanib (Injection) |
| Drug Classes | Ophthalmologic Agent |
| Active Ingredient | Pegaptanib sodium |
| Dosage Form | Injectable |
| Route | Intravitreal |
| Strength | eq 0.3mg acid/0.09ml |
| Market Status | Prescription |
| Company | Valeant Pharms |
| 2 of 2 | |
|---|---|
| Drug Name | Macugen |
| PubMed Health | Pegaptanib (Injection) |
| Drug Classes | Ophthalmologic Agent |
| Active Ingredient | Pegaptanib sodium |
| Dosage Form | Injectable |
| Route | Intravitreal |
| Strength | eq 0.3mg acid/0.09ml |
| Market Status | Prescription |
| Company | Valeant Pharms |